Meet Neo: The $20K Humanoid Butler Coming to Your Home (With a Big Catch!)
29 October 2025
3 mins read

Meet Neo: The $20K Humanoid Butler Coming to Your Home (With a Big Catch!)

  • 1X Technologies has opened pre-orders for Neo, a 5′6″ humanoid home assistant robot touted as “the world’s first consumer-ready humanoid” [1]. Neo will ship to early US customers in 2026 (with broader availability in 2027) and costs $20,000 upfront (or $499/month on subscription) [2] [3].
  • Task list: Neo can do basic chores – it can fold laundry, carry groceries, fetch items, toggle lights and even greet visitors [4] [5]. It has 22-degree-of-freedom arms and hands, can lift over 150 lbs, and operates quietly (just 22 dB of noise, quieter than a refrigerator) [6]. Onboard AI – including a built-in large-language model – gives Neo voice and visual recognition so it can chat with you, recognize faces/voices, suggest recipes from kitchen ingredients, and remember past conversations for personalized assistance [7] [8]. Neo even has speakers embedded in its chest and pelvis, essentially making it a moving smart speaker that can play music or podcasts at home [9].
  • Human in the loop: Crucially, Neo’s autonomy is still limited. If Neo encounters a task it hasn’t learned, the owner can summon a remote “1X Expert” – a real person at 1X – to teleoperate the robot and show it how to do the job [10]. In other words, Neo’s first outings may feel more like a remote-controlled helper than an independent robot. As one observer quipped, 1X’s tech is effectively “part human” right now, since remote operators can control the robot “as if it were a marionette” [11]. Early demos bear this out: Wall Street Journal reporter Joanna Stern found Neo could walk and carry objects, but tasks like grabbing a bottle from a fridge required a mix of autonomy and human control [12].
  • Backers and hype: 1X (founded by former Halodi Robotics engineers) is backed by heavy hitters. OpenAI led a $23.5 M Series A in 2023 and Samsung’s fund joined a $100 M round in 2024 [13] [14]. Nvidia has a strategic alliance (CEO Jensen Huang even accepted a custom jacket from Neo onstage), and other tech giants – from Tesla to Amazon – are plowing money into humanoid R&D [15] [16]. Investors have poured $3.2 B into humanoid startups in 2025 alone [17], and rivals have commanded stratospheric valuations (for example, Figure AI’s latest funding implied a ~$39 B valuation [18]). Wall Street analysts have likewise become bullish: Goldman Sachs projects a ~$38 B market by 2035, and a Morgan Stanley report even envisages as much as $5 trillion in humanoid robot revenues by 2050 (with over a billion units worldwide) [19] [20].
  • Experts’ reality check: Not everyone is convinced these robots are just around the corner. UC Berkeley robotics professor Ken Goldberg cautions that claims of a robot revolution are still hype: “robots are advancing quickly, but not that quickly,” he says. He emphasizes that dexterous tasks – like picking up a wine glass or changing a lightbulb – remain unsolved for machines [21] [22]. Goldberg warns Neo-level assistants won’t be ubiquitous “in the next two years, or five years or even 10 years,” and he urges resetting expectations so we don’t create a speculative bubble [23] [24]. Similarly, seasoned industry insiders note that today’s home robots are essentially “beta testing” the long journey to fully autonomous helpers [25] [26].
  • Stock and market impact: The humanoid buzz has rippled through the markets. Chipmaker Nvidia (NVDA) – which supplies AI processors to robotics firms – jumped roughly 5% on Oct 28 after CEO Huang’s positive keynote, reflecting investor enthusiasm for AI/robotics applications [27]. NVDA stock closed around $201 on Oct 28 and has an average analyst price target near $227 [28] [29]. Meanwhile, Tesla (NASDAQ: TSLA) – whose Optimus robot is a famous competitor – is trading around $460 per share [30]. Analysts’ forecasts for Tesla are mixed (targets range from about $247 to $520) [31], but the prospect of major robot revenues (Musk has hinted Tesla could one day earn most of its value from robots, not cars) keeps investors watching. In general, the surge of funding and high-profile demos suggests a booming market: some analysts now predict hundreds of billions in service-robot revenues within a decade [32] [33].

With its launch on Oct 28, Neo has become a symbol of both promise and reality in home robotics. It embodies the cutting edge of AI and mechanical engineering – and a hint of sci-fi-level convenience – but it also underscores how far we have to go. As 1X’s CEO and robotics experts alike note, Neo will improve over time through data and software updates, but for now early adopters are effectively helping to train the robot. In the words of one expert, Neo is a “bold glimpse of our robot-assisted future” – exciting, but not yet the household Rosie the Robot we’ve imagined [34] [35].

Sources: Recent reports from TechStock²/ts2.tech [36] [37], Fast Company [38] [39], the Indian Express [40] [41] and other tech media have covered Neo’s debut and specs. Market data are from financial news outlets [42] [43]. Robotics experts including UC Berkeley’s Ken Goldberg were interviewed by Berkeley News [44]. All facts and quotes are cited above.

Meet NEO, Your Robot Butler in Training | Bernt Børnich | TED

References

1. ts2.tech, 2. ts2.tech, 3. www.fastcompany.com, 4. ts2.tech, 5. indianexpress.com, 6. indianexpress.com, 7. ts2.tech, 8. indianexpress.com, 9. ts2.tech, 10. ts2.tech, 11. www.fastcompany.com, 12. ts2.tech, 13. ts2.tech, 14. www.fastcompany.com, 15. ts2.tech, 16. www.fastcompany.com, 17. ts2.tech, 18. ts2.tech, 19. ts2.tech, 20. www.fastcompany.com, 21. news.berkeley.edu, 22. news.berkeley.edu, 23. news.berkeley.edu, 24. news.berkeley.edu, 25. ts2.tech, 26. www.fastcompany.com, 27. www.barchart.com, 28. www.marketbeat.com, 29. www.marketbeat.com, 30. www.marketbeat.com, 31. www.marketbeat.com, 32. ts2.tech, 33. ts2.tech, 34. ts2.tech, 35. www.fastcompany.com, 36. ts2.tech, 37. ts2.tech, 38. www.fastcompany.com, 39. www.fastcompany.com, 40. indianexpress.com, 41. indianexpress.com, 42. www.marketbeat.com, 43. www.barchart.com, 44. news.berkeley.edu

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Stock Market Today

  • Merit Medical (MMSI) Q3 EPS and Revenue Surpass Estimates; Zacks Rank Holds
    October 30, 2025, 8:06 PM EDT. Merit Medical (MMSI) posted Q3 earnings of $0.86 per share, ahead of the Zacks consensus of $0.80, with adjusted results marking a 7.5% surprise. The company grew from $0.75 a year ago. Revenue came in at $339.85 million, topping the consensus by 1.4%. Over the last four quarters, Merit has beat estimates each time. Year-to-date, the stock has risen about 26.3%, above the S&P 500's 22.3%. For the coming quarter, the current consensus stands at $0.84 on $346.59 million in revenue, and for the full year at $3.30 on $1.34 billion. The shares carry a Zacks Rank #3 (Hold), suggesting the near term may move in line with the market while management commentary guides the outlook.
  • Fortune Brands Innovations (FBIN) Misses Q3 Earnings and Revenues; Zacks Rates Sell
    October 30, 2025, 8:04 PM EDT. Fortune Brands Innovations reported Q3 earnings of $1.09 per share, missing the Zacks consensus of $1.10. Revenue came in at $1.15 billion, short of the consensus by 2.43% and roughly flat versus a year ago ($1.16B). The company's quarterly result marks a -0.91% surprise on EPS, following a prior quarter beat of +2.04% (actual $1.00 vs estimate $0.98). Over the last four quarters, FBIN has beat estimates just once. The stock has fallen about 27.2% YTD, versus the S&P 500's +17.2%. The current Zacks Rank #4 (Sell) signals a cautious near-term outlook. For next quarter, consensus expects $1.04 per share on $1.12B revenue, and $3.78 on $4.54B for the year. Market mood may hinge on management commentary and industry trends.
  • Alerus (ALRS) Q3 Earnings Beat: EPS $0.66, Revenue $73.2M; Zacks Rank #2 (Buy)
    October 30, 2025, 8:02 PM EDT. Alerus (ALRS) reported Q3 earnings of $0.66 per share, beating the Zacks Consensus Estimate of $0.59. Revenue came in at $73.2 million, up from $50.9 million a year ago and ahead of the consensus by 2.31%. The results are adjusted for non-recurring items and show a quarterly surprise of +11.86%. The company previously posted $0.72 vs $0.56 expected, a +28.57% surprise. For the coming quarter, the current consensus calls for $0.58 on $71.45 million in revenue, with the full-year view at $2.44 on $285.3 million. Alerus holds a Zacks Rank #2 (Buy) as estimate revisions were favorable. YTD, shares are up about 9% versus the S&P 500's 17.2% gain.
  • Select Medical (SEM) Surpasses Q3 Earnings and Revenue Estimates
    October 30, 2025, 8:00 PM EDT. Select Medical (SEM) reported Q3 earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.18. On a year-over-year basis, earnings were $0.50 per share last year and were adjusted for non-recurring items, delivering a 27.78% earnings surprise. Revenue came in at $1.36 billion, topping the consensus by 2.87%. Over the last four quarters, the company has exceeded consensus EPS estimates twice and revenue estimates three times. The stock has shed about 24.2% year-to-date, underperforming the S&P 500 (+17.2%). Looking ahead, the near-term outlook hinges on management commentary. The current Zacks Rank #3 (Hold) implies returns in line with the market. For the coming quarter, the consensus is $0.26 on $1.36 billion in revenue, and for the full year, $1.18 on $5.38 billion in revenue.
  • Artesian Resources (ARTNA) Q3 Earnings Beat Estimates; Zacks Maintains Hold View
    October 30, 2025, 7:58 PM EDT. Artesian Resources (ARTNA) posted Q3 earnings of $0.68 per share, ahead of the Zacks Consensus of $0.66 and up from $0.66 a year ago (adjusted for non-recurring items). The quarter delivered a surprise of +3.03%, following a prior quarter with $0.61 versus $0.56 expected (+8.93%). Over the last four quarters, Artesian has beat consensus EPS three times. For the quarter ended September 2025, revenues were $30.49 million, topping the consensus by 1.64% vs $29.14 million year earlier. The stock has risen about 2.7% year-to-date versus the S&P 500's 17.2% gain. The near-term outlook remains tied to guidance and earnings revisions; the current Zacks Rank #3 (Hold) suggests the stock may move in line with the market. Analysts expect $0.37 in the next quarter on $28 million in revenue and $2.16 for the year on $112 million.
Go toTop